NCT03988491

Brief Summary

Background: In the last 2 decades, Tanzania made great improvements in the renal replacement therapy infrastructure and services. However, renal replacement therapy remains a challenge in the developing world in terms of inadequate renal registries, and limited published literature. Objectives: This study will identify predictors of mortality, identify common causes of infection and hospitalization, their incidences, prevalence, and time-to-event analysis and analyze short and long-term survival of end-stage renal disease (ESRD) patients on hemodialysis in two hemodialysis centers in Dodoma, Tanzania. Furthermore, this study will establish a registry to be called Tanzania Registry for Chronic Renal Failure (TRCRF). Methodology: This will be a prospective-observational study (Patient registry). It will be conducted in Tanzania, a developing world country involving two hemodialysis centers, namely Benjamin Mkapa Hospital and UDOM Health center, both affiliated with the University of Dodoma. Data will be collected by accessing patients' records receiving hemodialysis due to ESRD in the two centers from September 2019 to September 2024. Patients' demographics, medical history, investigation findings, and hemodialysis adequacy will be extracted as independent outcomes. In contrast, the outcome (i.e., Death) during the follow-up will be extracted as a primary dependent outcome. Binary logistic regression will be applied to come up with statistically significant predictors of deaths. Other outcomes will be incidences, prevalence, and time-to-event analysis of common causes of infection and re-hospitalization. Kaplan-Meier survival curves will be constructed from statistically significant predictors of deaths, and patients' survival at 1, 3, and 5 years will be illustrated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 17, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

August 11, 2020

Status Verified

August 1, 2020

Enrollment Period

5 years

First QC Date

June 11, 2019

Last Update Submit

August 7, 2020

Conditions

Keywords

Kidney Failure, ChronicMortalitySurvivalObservational StudyIncidenceRenal Dialysis

Outcome Measures

Primary Outcomes (2)

  • mortality

    To identify predictors for mortality among End-stage renal disease patients undergoing maintenance hemodialysis at UDOM (University of Dodoma) health center and Benjamin Mkapa Hospital using by binary logistic regression.

    5 Years

  • Survival

    To analyze survival of End-stage renal disease undergoing maintenance hemodialysis at 1, 3 and 5 years, at UDOM health center and Benjamin Mkapa Hospital, using Kaplan-Meier survival curves.

    5 Years

Secondary Outcomes (6)

  • Infection incidence

    5 Years

  • Infection prevalence

    5 Years

  • Time-to-infection survival

    5 Years

  • Incidences of rehospitalization

    5 Years

  • Prevalence of rehospitalization causes

    5 Years

  • +1 more secondary outcomes

Study Arms (1)

End stage renal disease on maintanance hemodialysis

End-stage renal disease due to any etiology on maintenance hemodialysis and consented to participate in the study.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

End stage renal disease patients requiring maintanance hemodialysis.

You may qualify if:

  • Participants diagnosed with end-stage renal disease due to any etiology.
  • Participants initiated on maintenance dialysis.
  • Participants attending Benjamin Mkapa Hospital or UDOM health center.
  • Eligible participants consented to participate in the study.

You may not qualify if:

  • Patients diagnosed with acute kidney injury.
  • Patients with CKD stage other than stage 5.
  • Patients underwent kidney transplantation.
  • Patients on dialysis other than hemodialysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benjamin Mkapa Hospital

Dodoma, 41218, Tanzania

RECRUITING

Related Publications (20)

  • Castro A, Neri M, Karopadi AN, Lorenzin A, Marchionna N, Ronco C. How can we advance in renal replacement therapy techniques? Nefrologia (Engl Ed). 2019 Jul-Aug;39(4):372-378. doi: 10.1016/j.nefro.2018.08.012. Epub 2019 Mar 4. English, Spanish.

    PMID: 30846291BACKGROUND
  • Obrador GT, Rubilar X, Agazzi E, Estefan J. The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective. Am J Kidney Dis. 2016 Mar;67(3):499-506. doi: 10.1053/j.ajkd.2015.08.033. Epub 2015 Dec 19.

    PMID: 26709109BACKGROUND
  • Almaguer M, Herrera R, Alfonso J, Magrans C, Manalich R, Martinez A. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int Suppl. 2005 Aug;(97):S4-10. doi: 10.1111/j.1523-1755.2005.09701.x.

    PMID: 16014098BACKGROUND
  • Schena FP. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney International. 2000;57:S39-S45.

    BACKGROUND
  • National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug. Report No.: 04-5230. Available from http://www.ncbi.nlm.nih.gov/books/NBK9630/

    PMID: 20821851BACKGROUND
  • Duong CM, Olszyna DP, Nguyen PD, McLaws ML. Challenges of hemodialysis in Vietnam: experience from the first standardized district dialysis unit in Ho Chi Minh City. BMC Nephrol. 2015 Aug 1;16:122. doi: 10.1186/s12882-015-0117-2.

    PMID: 26231882BACKGROUND
  • Bello BT, Raji YR, Sanusi I, Braimoh RW, Amira OC, Mabayoje OM. Challenges of providing maintenance hemodialysis in a resource poor country: Experience from a single teaching hospital in Lagos, Southwest Nigeria. Hemodial Int. 2013 Jul;17(3):427-33. doi: 10.1111/hdi.12024. Epub 2013 Feb 3.

    PMID: 23374329BACKGROUND
  • Prakash J, Ghosh B, Singh S, Soni A, Rathore SS. Causes of death in renal transplant recipients with functioning allograft. Indian J Nephrol. 2012 Jul;22(4):264-8. doi: 10.4103/0971-4065.101245.

    PMID: 23162269BACKGROUND
  • Kansal SK, Morfin JA, Weinhandl ED. Survival and Kidney Transplant Incidence on Home versus In-Center Hemodialysis, Following Peritoneal Dialysis Technique Failure. Perit Dial Int. 2019 Jan-Feb;39(1):25-34. doi: 10.3747/pdi.2017.00207. Epub 2018 Jul 31.

    PMID: 30065065BACKGROUND
  • Pauly RP. Survival comparison between intensive hemodialysis and transplantation in the context of the existing literature surrounding nocturnal and short-daily hemodialysis. Nephrol Dial Transplant. 2013 Jan;28(1):44-7. doi: 10.1093/ndt/gfs419.

    PMID: 23300280BACKGROUND
  • Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, Quinn RR. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities. Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.

    PMID: 29174322BACKGROUND
  • Aviles-Gomez R, Luquin-Arellano VH, Garcia-Garcia G, Ibarra-Hernandez M, Briseno-Renteria G. Is renal replacement therapy for all possible in developing countries? Ethn Dis. 2006 Spring;16(2 Suppl 2):S2-70-2.

    PMID: 16774015BACKGROUND
  • Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world--an Asian perspective. Perit Dial Int. 2001;21 Suppl 3:S307-13.

    PMID: 11887842BACKGROUND
  • Mushi L, Marschall P, Flessa S. The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Serv Res. 2015 Nov 12;15:506. doi: 10.1186/s12913-015-1166-8.

    PMID: 26563300BACKGROUND
  • Sadler JH. Health promotion for end-stage renal disease patients. Adv Ren Replace Ther. 1998 Oct;5(4):275-85. doi: 10.1016/s1073-4449(98)70019-6.

    PMID: 9792082BACKGROUND
  • Meremo AJ, Ngilangwa DP, Mwashambwa MY, Masalu MB, Kapinga J, Tagalile R, Sabi I. Challenges and outcomes of haemodialysis among patients presenting with kidney diseases in Dodoma, Tanzania. BMC Nephrol. 2017 Jul 4;18(1):212. doi: 10.1186/s12882-017-0634-2.

    PMID: 28676037BACKGROUND
  • Gupta I, Guin P. Communicable diseases in the South-East Asia Region of the World Health Organization: towards a more effective response. Bull World Health Organ. 2010 Mar;88(3):199-205. doi: 10.2471/BLT.09.065540.

    PMID: 20428387BACKGROUND
  • Nyaaba GN, Stronks K, de-Graft Aikins A, Kengne AP, Agyemang C. Tracing Africa's progress towards implementing the Non-Communicable Diseases Global action plan 2013-2020: a synthesis of WHO country profile reports. BMC Public Health. 2017 Apr 5;17(1):297. doi: 10.1186/s12889-017-4199-6.

    PMID: 28381252BACKGROUND
  • Davids MR, Caskey FJ, Young T, Balbir Singh GK. Strengthening Renal Registries and ESRD Research in Africa. Semin Nephrol. 2017 May;37(3):211-223. doi: 10.1016/j.semnephrol.2017.02.002.

    PMID: 28532551BACKGROUND
  • Jha V, Chugh K. Dialysis in developing countries: Priorities and obstacles2007. 65-71 p.

    BACKGROUND

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Joel D Swai, MMed

    Benjamin Mkapa Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician-Internal Medicine Department

Study Record Dates

First Submitted

June 11, 2019

First Posted

June 17, 2019

Study Start

August 1, 2020

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

August 11, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations